ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry").
Saved in:
| Title: | ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry"). |
|---|---|
| Authors: | Cecchi I; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, Turin, Italy.; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy., Radin M; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, Turin, Italy.; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy., Foddai SG; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, Turin, Italy.; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy., Barinotti A; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, Turin, Italy.; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy., Andrade D; University of São Paulo, São Paulo, Brazil., Tektonidou MG; National and Kapodistrian University of Athens, Athens, Greece., Pengo V; Senior Scientist, University of Padova, Italy., Ruiz-Irastorza G; Autoinmune Diseases Research Unit, Biobizkaia Health Research Institute, UPV/EHU, Barakaldo, Spain., Belmont HM; New York University Langone Medical Center, New York, NY, USA., Lopez Pedrera C; Rheumatology Service/Department of Medical and Surgical Sciences, Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Córdoba, Spain., Fortin PR; Centre ARThrite-CHU de Québec - Université Laval, Quebec, QC, Canada., Gerosa M; University of Milan, Milan, Italy., de Jesús G; Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil., Atsumi T; Hokkaido University Hospital, Sapporo, Japan., Ji L; Peking University First Hospital, Beijing, China., Efthymiou M; University College London, London, UK., Branch DW; University of Utah and Intermountain Healthcare, Salt Lake City, UT, USA., Nalli C; University of Brescia, Brescia, Italy., Rodriguez-Almaraz E; Hospital Universitario, 12 de Octubre, Madrid, Spain., Petri M; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Cervera R; Department of Autoimmune Diseases, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Catalonia,Spain., Knight JS; University of Michigan, Ann Arbor, MI, USA., Artim-Esen B; Istanbul University School of Medicine, Istanbul, Turkey., Willis R; University of Texas Medical Branch, Galveston, TX, USA., Bertolaccini ML; School of Cardiovascular & Metabolic Medicine & Sciences, King's College London, London, UK., Cohen H; University College London, London, UK., Erkan D; Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, USA., Sciascia S; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, Turin, Italy.; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy. |
| Source: | Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2025 May 01; Vol. 64 (5), pp. 2862-2867. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1462-0332 |
|---|---|
| DOI: | 10.1093/rheumatology/keae583 |
